The GLP-1 activity counterbalances the blood sugar raising effect of glucagon, so the net result is more fat burned without blood sugar problems
(PubMed) Taylor EN, Stampfer MJ, Curhan GC
Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment
The first proposed use of POTABA to treat PD was in 1959 by Zarafonetis and Horrax (7)
Potential Key Benefits* Supports natural detoxification and liver function Promotes bright, even-toned, glowing skin May help neutralize free radicals and reduce oxidative stress Supports immune health and cellular repair Encourages collagen protection and skin clarity Promotes the recycling of antioxidants like vitamins C and E Supports overall vitality and resilience Absorption Rate (Bioavailability): Up to 80% 92% Price is for 1 box
2-page printable handout Prepared by Danielle Alcala-Glazier All handouts are educational not medical advice